Table 3.
Cox regression analysis of factors associated with LTFU among adult patients on ART therapy at Karamara General Hospital, September 2007 to September 2014, Somali region, Jigjiga town, Eastern Ethiopia, 2015
| Variables | Loss to Follow Up | AHR | P- Value | |
|---|---|---|---|---|
| Yes | No | (95% CI) | ||
| Sex | ||||
| Male | 107 (34.2) | 498 (65.8) | 2.1 (1.3–3.4) | 0.034* |
| Female | 106 (24.7) | 728 (75.3) | 1 | |
| Next appointment recorded properly | ||||
| Yes | 190 (17.4) | 902 (82.6) | 1 | 0.000* |
| No | 23 (6.6) | 324 (93.4) | 1.2 (1.12–1.36) | |
| History of TB treatment | ||||
| Yes | 71 (19.4) | 296 (80.6) | 1.2 (0.08–1.38) | |
| No | 142 (13.2) | 930 (86.8) | 1 | 0.561 |
| WHO Stagea | ||||
| I | 38 (11.6) | 290 (88.4) | 1 | |
| II | 29 (12.7) | 199 (87.3) | 0.4 (0.34–2.34) | 0.341 |
| III | 111 (16.6) | 559 (83.4) | 0.8 (0.40–1.17) | 0.123 |
| IV | 35 (16.4) | 178 (83.6) | 0.6 (0.28–1.43) | 0.112 |
| Functional statusb | ||||
| Functional | 81 (10.0) | 730 (90.0) | 1 | |
| Ambulatory | 96 (19.6) | 392 (80.4) | 0.73 (0.44–1.2) | 0.2213 |
| Bed ridden | 36 (25.7) | 104 (74.3) | 1.31 (0.86–1.9) | 0.2364 |
| CD4 Count | ||||
| = < 200 | 152 (16.3) | 783 (83.7) | 0.7 (0.5–1.0) | 0.117 |
| 201–250 | 21 (10.8) | 174 (89.2) | 0.6 (0.4–1.8) | 0.712 |
| 251–300 | 16 (8.2) | 180 (91.8) | 0.7 (0.6–1.0) | 0.371 |
| 301–350 | 10 (8.9) | 103 (91.1) | 0.9 (1.1–1.8) | 0.682 |
| > = 351 | 14 (12.4) | 99 (87.6) | 1 | |
| Disclosure status | ||||
| Disclosed to any one | 76 (7.0) | 1005 (93.0) | 1 | |
| Not disclosed to any one | 137 (38.3) | 221 (61.7) | 2.8 (2.22–5.23) | 0.034* |
Note
*statistically significant at p-value < 0.05
ais based on the clinical sign and symptom complex
bFunctional = able to perform usual work in or out of the house, harvest, go to school
Ambulatory = able to perform activities of daily living but not able to work or play
Bedridden = not able to perform activities of daily living